NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
Clinical Trials
7 trialsNCT00883909 2017-07-11
ARI103094-Follow-Up Study for REDUCE Study Subjects
GlaxoSmithKline
Completed
NCT01337258 2017-05-30
Economic Analyses of the REDUCE Trial
GlaxoSmithKline
Completed
NCT01371513 2017-05-22
RESPECT
GlaxoSmithKline
Completed
NCT01767363 2016-11-09
WEUSKOP5723: Prostate Cancer Study
GlaxoSmithKline
Completed
NCT00822952 2014-03-31
PMI
Artann Laboratories
Completed
NCT00400894 2007-02-05
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
ProteoSys AG
Unknown